PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,519 | -10.8% | 16,534 | -9.1% | 0.06% | -7.5% |
| Q2 2023 | $113,832 | +129.0% | 18,184 | +74.5% | 0.07% | +148.1% |
| Q1 2023 | $49,713 | -60.4% | 10,422 | -27.8% | 0.03% | -59.1% |
| Q4 2022 | $125,498 | -4.9% | 14,425 | +30.4% | 0.07% | +24.5% |
| Q3 2022 | $132,000 | -15.9% | 11,061 | +0.7% | 0.05% | -8.6% |
| Q2 2022 | $157,000 | +12.1% | 10,986 | +62.9% | 0.06% | -7.9% |
| Q1 2022 | $140,000 | -15.2% | 6,746 | -5.7% | 0.06% | +1.6% |
| Q4 2021 | $165,000 | -11.3% | 7,151 | +14.8% | 0.06% | -24.4% |
| Q3 2021 | $186,000 | -17.0% | 6,229 | -5.0% | 0.08% | -10.9% |
| Q2 2021 | $224,000 | – | 6,556 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |